Why ADMA Biologics, Inc. (ADMA) stock rose 26.1% on Thursday, November 5, 2026

ADMA Biologics, Inc. (ADMA) closed at $13.21, up 26.05% on Thursday, November 5, 2026, on volume of 14,969,105 shares (5.2× its 3-month average); market value about $3.00B.

What happened: primary sources

Events Nexqual found for ADMA on Thursday, November 5, 2026 or the trading day before (November 4, 2026):

• Nov 4, 2026: Reported Q3 2026 results: EPS $0.22 vs consensus $0.20 (beat), revenue $141.1M vs consensus $138.1M (beat). Guidance: FY2026 total revenue expected to be at least $530 million. source
• Nov 5, 2026: Cantor Fitzgerald: Target raised, Neutral, price target $12 → $13

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on ADMA

ADMA stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: ADMA results, November 4, 2026. Other big moves that day: November 5, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:39 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:39 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt